| Report ID | 280781 |
| Drug Identification Number | 02243676 |
| Brand name | RECOMBIVAX HB |
| Common or Proper name | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SUSPENSION SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 5MCG/0.5ML 1DOSE VIAL |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2026-03-16 |
| Actual start date | 2026-03-16 |
| Estimated end date | 2026-04-23 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-18 |
| Company comments | Delay in availability of alternate format. Remaining doses are reserved for the public immunization program. / Retard dans la disponibilité du format alternatif. Les doses restantes sont réservées au programme public de vaccination. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-18 | French | Compare |
| v1 | 2026-03-18 | English | Compare |
Showing 1 to 2 of 2